CD16-II variants
US5998166A · kind A · utility
9Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 24, 1996 |
| Grant date | Dec 7, 1999 |
| Priority date | — |
| Expiry date | Jun 24, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Human CD16-II variants, DNA sequences coding for them, their use in therapy and/or in diagnosis of autoimmune diseases and inflammatory illnesses, as well as pharmaceutical compositions comprising them, are disclosed. The sequence listing for the new polypeptides is provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.